<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Collingwood Health Group</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
            in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
            mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
            population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
        </p>
        <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
            it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
        </p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=practice+A87004">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
            send short or detailed feedback.
        </p>
        <h2>Prescribing where Collingwood Health Group is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601023AI&amp;denomIds=6.1.2&amp;selectedTab=summary">Lixisenatide</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>34</td>
      <td>Other antidiabetic drugs</td>
      <td>738</td>
      <td>0.05</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>7.16</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601023AIAAACAC&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Lixisenatide 10microg/0.2ml and 20microg/0.2ml inj : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601023AIAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Lixisenatide 10micrograms/0.2ml inj 3ml pf dispos dev : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601023AIBBAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Lyxumia 20micrograms/0.2ml inj 3ml pre-filled pens : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601023AIAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Lixisenatide 20micrograms/0.2ml inj 3ml pf dispos dev : 27</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0901030N0&amp;denomIds=9.1.3&amp;selectedTab=summary">Methoxy polyethylene glycol-epoetin beta</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Hypoplastic/haemolytic and renal anaemias</td>
      <td>1</td>
      <td>1.00</td>
      <td>0.04</td>
      <td>0.20</td>
      <td>4.85</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAFsElEQVR4nO3dXagUZRzH8e/oKQnTTCohAofeIHoRCstjphUowUhBEBUUXRjmTQZd5EgXelExJr1fJJZS3gR2kZpDRFEqSYYk1VWlF3OREV6Ydcry9d/FzNqedY/snp2ZZ93n94Fh9+zZ8zy/M2f/u3NmnmcmMDNExA8TXAcQkfqo4EU8ooIX8YgKXsQjKngRj6jgRTyighfxiApexCMqeBGPqOBFPKKCF6lbEDgbzz7Uyw+HcboV2AxszZLor3IiiUhVev2EfwOYD+wL4/SGEvKISIWCMmbLhXF6D7AReDxLoq96blBkkAWBYRY46bqs6bFhnM4CtgALsyQ6UEqjIoPIYcGXttMuS6LvgWeAD8I4nVRWuyJSnlL30mdJtA3YDSRltisi5ajisNwK4N4wTudW0LaI9KD0gs+S6BjwNPBmGKcTy25fRMavkoE3WRLtAn4CnqyifREZnypH2j0HrAzjdHqFfYhIFyor+CyJDgLvAnFVfYhId6oeS/8a8FAYp1dV3I+IdKDSgs+S6G9gLbC6yn5EpDN1zJZ7B5insfYi7lVe8FkSnSD/hH+x6r5E5Nzqmg+/GZgZxumcmvoTkTZqKfgsiU4DK4EkjFMnkwZEpN4z3nwGnALuq7FPEWlS2vTYToRxOhtYD9xWfOqL+GcQpsd2IkuivcAB4NE6+xWRnIuTWD4PrNKceZH61V7wWRL9DHwBPFV33yK+c3Wa6tXAs2GcznDUv4iXnBR8lkS/Aa8AL7voX8RXLi9E8TZwUxinCxxmEPFKrYflWoVxegf56a1nZ0l01FkQkTr5cliuVZZE3wBbyTfvRaRi/XBtuVXArWGcPuA6iMigc7pJ3xDG6bXkQ28XZUm033UekUr5uknfUFypZhmwLYzTK1znERlUfVHwAFkSfUp+dpxtYZxOdZ1HZBD1TcEDZEm0kXzu/I4wTq90nUdk0PRVwQNkSfQq+YCcncXsOhEpSV/stGsnjNNhYAOQAqt0nF4GxiBcLroKYZxeRD7u/mHyefTrsiQ67DSUSK9U8OdWTLJZDjwG/Ah8DOwBfsiS6LjLbOKvME6HgGnA9GK5tM3tFGAScGFxO5StWRyFK7Z/CJwAjgMjwJFi+b3p/hHgcPHYSJZEPRfreVHwDWGcTgDmkJ8m63bgZuAk8CvwC3CQfCUdbVqOAac7XBrvukFFS2vbdPi9bp7bSTu0/N6nxlgf7R7v5LHGiyoY43a83yvz5ycCFxTLhWPcnwxMLZYpTfcvIS/ek4wuyubbM4VK/ho8XiwnszWL94Yrts8v+pgEXEz+xjGN/E2i+X7jzWNKkfvPot1GPyNZEi2jQz0VfBAES81s/bgbqIEylkMZy+MyZ6976ZeWkqJaylgOZSyPs5x9d1hORKqjghfxSK8F3/f/L6GMZVHG8jjLeV7tpReR3miTXsQjQ908OQiC+cBc4JCZbQyC4EHgGuCAmX1URcButcn4BHAj8ImZfek23f9acxaPrQPeM7M9TsMV2qzLu4BhYI+Z7XKbLtcm4xKKY9Zm9rrTcIUgCO4GlpnZI8XXS4AZwE4z211nlm4/4YfNLAEuL76+zszWAteXG6snozKa2fvAOuBqp6nONipn8ea5w2mis7X+ve8H/iEfXNMvWjNOJC+mQ+4ijWZmO4Dvmh66zMxeAubVnaXbgm/9h78fdwCMyhQEwWRgCbDJTZwxta67W8hfAHc6yDKW1oxTzewtYJGLMGNozTjBzFaSb3n2K2d109VOu2LzaZh8SN8+YCb5it1vZlsqSdilNhmXk1/P7nMz+9pltmatOc3s22LT798+26Rv/XuHwB9mtsFhtDPaZFxAPoR2pF9G3QVBMAt4gXz+xyZgIflWyK66N+m1l17EI9pLL+IRFbyIR1TwIh5RwYt4RAUv4hEVvIhHVPAiHlHBi3hEBS/iERW8iEdU8CIe+Q8yeercJxKiagAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0901030N0AAADAD&amp;denomIds=9.1.3&amp;selectedTab=summary" target="_blank">Methoxy polyethylene glycol-epoetin beta 150microg/0.3ml inj : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=1106000AK&amp;denomIds=11.6&amp;selectedTab=summary">Tafluprost</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>79</td>
      <td>Treatment of glaucoma</td>
      <td>1379</td>
      <td>0.06</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>4.69</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=1106000AKAAAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Tafluprost 15micrograms/ml eye dps 0.3ml ud preserv free : 60</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=1106000AKBBAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Saflutan 15micrograms/ml eye drops 0.3ml unit dose : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=1106000AKBBABAB&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Saflutan 15micrograms/ml eye drops : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0704020G0&amp;denomIds=7.4.2&amp;selectedTab=summary">Flavoxate hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>49</td>
      <td>Drugs for urinary frequency enuresis and incontinence</td>
      <td>1863</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>4.32</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0704020G0AAACAC&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Flavoxate 200mg tablets : 49</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=1308010U0&amp;denomIds=13.8.1&amp;selectedTab=summary">Titanium dioxide</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Sunscreening preparations</td>
      <td>42</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>4.32</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=1308010U0AAALAL&amp;denomIds=13.8.1&amp;selectedTab=summary" target="_blank">Reflectant sunscreen coral pink (Dundee formula) cream : 1</a></div></td></tr></tbody></table>

        <h2>Prescribing where Collingwood Health Group is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0301020Q0&amp;denomIds=3.1.2&amp;selectedTab=summary">Tiotropium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>243</td>
      <td>Antimuscarinic bronchodilators</td>
      <td>858</td>
      <td>0.28</td>
      <td>0.71</td>
      <td>0.18</td>
      <td>-2.33</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0301020Q0AAABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation powder capsules : 68</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0301020Q0BBABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva 18microgram inhalation powder capsules : 92</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0301020Q0BBACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln : 46</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0301020Q0AAAEAE&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 2.5micrograms/dose inhalation soln cart : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0301020Q0AAAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation pdr caps with dev : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0301020Q0BBAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva 18microgram inhalation pdr caps with HandiHaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0301020Q0BBADAE&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln refill cart : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0301020Q0AAACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium brom 2.5microg/dose soln for inhalation CFCfree : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=1501030G0&amp;denomIds=15.1.3&amp;selectedTab=summary">Glycopyrronium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Antimuscarinic drugs</td>
      <td>4</td>
      <td>0.00</td>
      <td>0.82</td>
      <td>0.36</td>
      <td>-2.30</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0209000A0&amp;denomIds=2.9&amp;selectedTab=summary">Aspirin</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3589</td>
      <td>Antiplatelet drugs</td>
      <td>6971</td>
      <td>0.51</td>
      <td>0.65</td>
      <td>0.06</td>
      <td>-2.27</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0209000A0AAABAB&amp;denomIds=2.9&amp;selectedTab=summary" target="_blank">Aspirin 75mg dispersible tablets : 3107</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0209000A0AAAJAJ&amp;denomIds=2.9&amp;selectedTab=summary" target="_blank">Aspirin 75mg tablets : 139</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0209000A0AAAKAK&amp;denomIds=2.9&amp;selectedTab=summary" target="_blank">Aspirin 75mg gastro-resistant tablets : 343</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0&amp;denomIds=4.7.1&amp;selectedTab=summary">Co-codamol (Codeine phosphate/paracetamol)</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1055</td>
      <td>Non-opioid analgesics and compound preparations</td>
      <td>7695</td>
      <td>0.14</td>
      <td>0.45</td>
      <td>0.15</td>
      <td>-2.04</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0AAAAAA&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg tablets : 536</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0AAACAC&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg effervescent tablets : 126</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0AAADAD&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 30mg/500mg capsules : 74</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0AAAFAF&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 30mg/500mg effervescent tablets : 49</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0AAAHAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 30mg/500mg tablets : 157</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0AAAKAK&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 15mg/500mg tablets : 83</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0AAAVAV&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 15mg/500mg capsules : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0BSAAAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Zapain 30mg/500mg tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0AAABAB&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg capsules : 13</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0BEAAAD&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Tylex 30mg/500mg capsules : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0407010F0BGABAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Solpadol 30mg/500mg caplets : 11</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601012V0&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin glargine</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>74</td>
      <td>Intermediate and long-acting insulins</td>
      <td>1093</td>
      <td>0.07</td>
      <td>0.33</td>
      <td>0.13</td>
      <td>-1.98</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601012V0BBAEAD&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Lantus 100units/ml inj 3ml pre-filled SoloStar pens : 41</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601012V0BDACAD&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Abasaglar KwikPen 100units/ml inj 3ml pre-filled pens : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601012V0AAAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Insulin glargine 100units/ml inj 3ml cartridges : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601012V0BBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Lantus 100units/ml solution for injection 10ml vials : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601012V0BBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Lantus 100units/ml solution for injection 3ml cartridges : 23</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=A87004&amp;numIds=0601012V0BCAAAE&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Toujeo 300units/ml inj 1.5ml pre-filled SoloStar pens : 6</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>